StockWatch
·
Pharmaceuticals
AGM/EGM2 Oct 2026, 06:00 pm

Ishita Drugs reappoints Director post 75 years, auditor

AI Summary

Ishita Drugs & Industries Ltd announced the re-appointment of Mrs. Abha Agrawal as a Non-Executive Non-Independent Director, who has attained the age of 75 years. This decision was approved by the members at the 33rd Annual General Meeting (AGM) held on September 30, 2026. Mrs. Agrawal, a promoter with over 30 years of experience in chemicals and electrical switches, is the spouse of the Managing Director. Additionally, M/s. Jaymin Shah & Associates were re-appointed as the Statutory Auditors for the upcoming fiscal year, from the conclusion of the 33rd AGM until the 34th AGM. The company also disclosed details regarding the re-appointment of Mrs. Agrawal, including her profile and relationship disclosures, as per SEBI Listing Regulations.

Key Highlights

  • Mrs. Abha Agrawal re-appointed as Non-Executive Non-Independent Director.
  • Re-appointment approved at the 33rd Annual General Meeting.
  • Jaymin Shah & Associates re-appointed as Statutory Auditors.
  • Director re-appointment is post attaining the age of 75 years.